A restricted level of PQBP1 is needed for the best longevity of Drosophila

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 356.e11-356.e20

  Tamura, Takuya ^a   Sone, Masaki ^b   Nakamura, Yoko ^a   Shimamura, Teppei ^c   Imoto, Seiya ^c   Miyano, Satoru ^c   Okazawa, Hitoshi ^a,b,d  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Drosophila; Lifespan; Longevity; PQBP1; RNA

Indexed keywords

EID: 84868137314     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.07.015     Document Type: Article

References (44)

1. Bhattacharya M.R., Gerdts J., Naylor S.A., Royse E.X., Ebstein S.Y., Sasaki Y., Milbrandt J., Diantonio A. A model of toxic neuropathy in drosophila reveals a role for MORN4 in promoting axonal degeneration. J. Neurosci 2012, 32:5054-5061.
2. Buratti E., Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem 2001, 276:36337-36343.
3. Buratti E., Baralle F.E. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci 2008, 13:867-878.
4. Crozat A., Aman P., Mandahl N., Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993, 363:640-644.
5. Dalal S., Rosser M.F., Cyr D.M., Hanson P.I. Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway. Mol. Biol. Cell 2004, 15:637-648.
6. Fang Y., Soares L., Teng X., Geary M., Bonini N.M. A novel Drosophila model of nerve injury reveals an essential role of nmnat in maintaining axonal integrity. Curr. Biol 2010, 22:590-595.
7. Fischer A., Sananbenesi F., Mungenast A., Tsai L.H. Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol. Sci 2010, 31:605-617.
8. Flynn M., Zou Y.S., Milunsky A. Whole gene duplication of the PQBP1 gene in syndrome resembling Renpenning. Am. J. Med. Genet 2011, A 155A:141-144.
9. Georgi L.L., Albert P.S., Riddle D.L. daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell 1990, 61:635-645.
10. Guarente L., Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000, 408:255-262.
11. Hagerman R., Au J., Hagerman P. FMR1 premutation and full mutation molecular mechanisms related to autism. J. Neurodev. Disord 2011, 3:211-224.
12. Herranz D., Serrano M. SIRT1: recent lessons from mouse models. Nat. Rev. Cancer 2010, 10:819-823.
13. Honda S., Hayashi S., Imoto I., Toyama J., Okazawa H., Nakagawa E., Goto Y., Inazawa J. Copy-number variations on the X chromosome in Japanese patients with mental retardation detected by array-based comparative genomic hybridization analysis. J. Hum. Genet 2010, 55:590-599.
14. Honkura N., Matsuzaki M., Noguchi J., Ellis-Davies G.C., Kasai H. The subspine organization of actin fibers regulates the structure and plasticity of dendritic spines. Neuron 2008, 57:719-729.
15. Iguchi Y., Katsuno M., Niwa J., Yamada S., Sone J., Waza M., Adachi H., Tanaka F., Nagata K., Arimura N., Watanabe T., Kaibuchi K., Sobue G. TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases. J. Biol. Chem 2009, 284:22059-22066.
16. Imafuku I., Waragai M., Takeuchi S., Kanazawa I., Kawabata M., Mouradian M.M., Okazawa H. Polar amino acid-rich sequences bind to polyglutamine tracts. Biochem. Biophys. Res. Commun 1998, 253:16-20.
17. Ito H., Yoshimura N., Kurosawa M., Ishii S., Nukina N., Okazawa H. Knock-down of PQBP1 impairs anxiety-related cognition in mouse. Hum. Mol. Genet 2009, 18:4239-4254.
18. Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol 2009, 187:875-888.
19. Kalscheuer V.M., Freude K., Musante L., Jensen L.R., Yntema H.G., Gécz J., Sefiani A., Hoffmann K., Moser B., Haas S., Gurok U., Haesler S., Aranda B., Nshedjan A., Tzschach A., Hartmann N., Roloff T.C., Shoichet S., Hagens O., Tao J., Van Bokhoven H., Turner G., Chelly J., Moraine C., Fryns J.P., Nuber U., Hoeltzenbein M., Scharff C., Scherthan H., Lenzner S., Hamel B.C., Schweiger S., Ropers H.H. Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat. Genet 2003, 35:313-315.
20. Kang H.L., Benzer S., Min K.T. Life extension in Drosophila by feeding a drug. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:838-843.
21. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
22. Kleefstra T., Franken C.E., Arens Y.H., Ramakers G.J., Yntema H.G., Sistermans E.A., Hulsmans C.F., Nillesen W.N., van Bokhoven H., de Vries B.B., Hamel B.C. Genotype-phenotype studies in three families with mutations in the polyglutamine-binding protein 1 gene (PQBP1). Clin. Genet 2004, 66:318-326.
23. Laggerbauer B., Ostareck D., Keidel E.M., Ostareck-Lederer A., Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet 2001, 10:329-338.
24. Lenski C., Abidi F., Meindl A., Gibson A., Platzer M., Frank Kooy R., Lubs H.A., Stevenson R.E., Ramser J., Schwartz C.E. Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. Am. J. Hum. Genet 2004, 74:777-780.
25. Llorian M., Beullens M., Andrés I., Ortiz J.M., Bollen M. SIPP1, a novel pre-mRNA splicing factor and interactor of protein phosphatase-1. Biochem. J 2004, 378:229-238.
26. Mimnaugh E.G., Xu W., Vos M., Yuan X., Neckers L. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol. Cancer Res 2006, 4:667-681.
27. Nonhoff U., Ralser M., Welzel F., Piccini I., Balzereit D., Yaspo M.L., Lehrach H., Krobitsch S. Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol. Biol. Cell 2007, 18:1385-1396.
28. Okazawa H., Rich T., Chang A., Lin X., Waragai M., Kajikawa M., Enokido Y., Komuro A., Kato S., Shibata M., Hatanaka H., Mouradian M.M., Sudol M., Kanazawa I. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 2002, 34:701-713.
29. Okuda T., Hattori H., Takeuchi S., Shimizu J., Ueda H., Palvimo J.J., Kanazawa I., Kawano H., Nakagawa M., Okazawa H. PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype. Hum. Mol. Genet 2003, 12:711-725.
30. Paaby A.B., Schmidt P.S. Dissecting the genetics of longevity in Drosophila melanogaster. Fly (Austin) 2009, 3:29-38.
31. Poirier K., Lacombe D., Gilbert-Dussardier B., Raynaud M., Desportes V., de Brouwer A.P., Moraine C., Fryns J.P., Ropers H.H., Beldjord C., Chelly J., Bienvenu T. Screening of ARX in mental retardation families: Consequences for the strategy of molecular diagnosis. Neurogenetics 2006, 7:39-46.
32. Qi Y., Hoshino M., Wada Y., Marubuchi S., Yoshimura N., Kanazawa I., Shinomiya K., Okazawa H. PQBP-1 is expressed predominantly in the central nervous system during development. Eur. J. Neurosci 2005, 22:1277-1286.
33. +-sensitive pathway in insects and mammals. J. Neurosci 2010, 30:6375-6386.
34. Sephton C.F., Good S.K., Atkin S., Dewey C.M., Mayer P., Herz J., Yu G. TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem 2010, 285:6826-6834.
35. Shibata H., Huynh D.P., Pulst S.M. A novel protein with RNA-binding motifs interacts with ataxin-2. Hum. Mol. Genet 2000, 9:1303-1313.
36. Siomi H., Choi M., Siomi M.C., Nussbaum R.L., Dreyfuss G. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 1994, 77:33-39.
37. Stevenson R.E., Bennett C.W., Abidi F., Kleefstra T., Porteous M., Simensen R.J., Lubs H.A., Hamel B.C., Schwartz C.E. Renpenning syndrome comes into focus. Am. J. Med. Genet. A 2005, 134:415-421.
38. Takahashi K., Yoshina S., Masashi M., Ito W., Inoue T., Shiwaku H., Arai H., Mitani S., Okazawa H. Nematode homologue of PQBP1, a mental retardation causative gene, is involved in lipid metabolism. PLoS One 2009, 4:e4104.
39. Tamura T., Horiuchi D., Chen Y.C., Sone M., Miyashita T., Saitoe M., Yoshimura N., Chiang A.S., Okazawa H. Drosophila PQBP1 regulates learning acquisition at projection neurons in aversive olfactory conditioning. J. Neurosci 2010, 30:14091-14101.
40. Uchida A., Sasaguri H., Kimura N., Tajiri M., Ohkubo T., Ono F., Sakaue F., Kanai K., Hirai T., Sano T., Shibuya K., Kobayashi M., Yamamoto M., Yokota S., Kubodera T., Tomori M., Sakaki K., Enomoto M., Hirai Y., Kumagai J., Yasutomi Y., Mochizuki H., Kuwabara S., Uchihara T., Mizusawa H., Yokota T. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain 2012, 135:833-846.
41. Waragai M., Junn E., Kajikawa M., Takeuchi S., Kanazawa I., Shibata M., Mouradian M.M., Okazawa H. PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain. Biochem. Biophys. Res. Commun 2000, 273:592-595.
42. Waragai M., Lammers C.H., Takeuchi S., Imafuku I., Udagawa Y., Kanazawa I., Kawabata M., Mouradian M.M., Okazawa H. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet 1999, 8:977-987.
43. Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18809-18814.
44. Wójcik C., Yano M., DeMartino G.N. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J. Cell Sci 2004, 117:281-292.